Template:Lactic acidosis DDX: Difference between revisions

Line 13: Line 13:
***Mainly due to D-lactate production, though hypovolemia contributes
***Mainly due to D-lactate production, though hypovolemia contributes
**[[hepatic failure|Liver disease]] (decreased clearance)
**[[hepatic failure|Liver disease]] (decreased clearance)
**Adrenergic receptor agonism; viz., albuterol, epinephrine, etc
**Adrenergic receptor agonism; viz., [[albuterol]], [[epinephrine]], etc
**Malignancy
**Malignancy
**[[Carbon Monoxide]] poisoning
**[[Carbon Monoxide]] poisoning

Revision as of 01:05, 7 March 2021

Lactic acidosis

By Type

  • Type A (tissue hypoperfusion)
  • Type B (decreased utilization)
  • Type D
    • episodes of encephalopathy and metabolic acidosis typically following high carbohydrate meals in patients with short bowel syndrome
    • metabolic acidosis and high serum anion gap, normal lactate level, short bowel syn or other forms of malabsorption, and characteristic neurologic findings
      • Type D lactate is not detected with standard lactate levels

Complete List

  1. Dodda V and Spiro P. Albuterol, an Uncommonly Recognized Culprit in Lactic Acidosis. Chest. 2011;140.